 Hui Zhang
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 20 | 2024 | 1957 | 2.550 |
Why?
| | Fibroblasts | 9 | 2024 | 1025 | 1.230 |
Why?
| | MicroRNAs | 4 | 2021 | 686 | 0.910 |
Why?
| | Polypyrimidine Tract-Binding Protein | 3 | 2017 | 16 | 0.680 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2017 | 18 | 0.660 |
Why?
| | Pyruvate Kinase | 2 | 2017 | 28 | 0.650 |
Why?
| | Immunotoxins | 3 | 2025 | 55 | 0.600 |
Why?
| | Disease Susceptibility | 1 | 2021 | 344 | 0.590 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 447 | 0.480 |
Why?
| | Histone Deacetylase Inhibitors | 3 | 2023 | 218 | 0.430 |
Why?
| | Hypoxia | 8 | 2024 | 1199 | 0.420 |
Why?
| | Diphtheria Toxin | 3 | 2025 | 65 | 0.420 |
Why?
| | Pulmonary Artery | 6 | 2024 | 1127 | 0.420 |
Why?
| | Gene Expression Regulation | 4 | 2021 | 2597 | 0.410 |
Why?
| | Vascular Remodeling | 4 | 2023 | 209 | 0.350 |
Why?
| | Cellular Reprogramming | 3 | 2021 | 98 | 0.320 |
Why?
| | Animals | 25 | 2025 | 38030 | 0.310 |
Why?
| | Cell Proliferation | 6 | 2023 | 2507 | 0.310 |
Why?
| | Familial Primary Pulmonary Hypertension | 3 | 2017 | 196 | 0.260 |
Why?
| | Interleukin-2 | 3 | 2024 | 440 | 0.260 |
Why?
| | Macrophages | 6 | 2022 | 1507 | 0.250 |
Why?
| | Cattle | 5 | 2023 | 946 | 0.230 |
Why?
| | Glycolysis | 5 | 2017 | 340 | 0.220 |
Why?
| | Lignans | 1 | 2024 | 12 | 0.220 |
Why?
| | CD47 Antigen | 1 | 2025 | 42 | 0.210 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 26 | 0.210 |
Why?
| | Biphenyl Compounds | 1 | 2024 | 67 | 0.210 |
Why?
| | NAD | 1 | 2024 | 79 | 0.210 |
Why?
| | Mice | 14 | 2025 | 18329 | 0.210 |
Why?
| | Signal Transduction | 5 | 2024 | 5216 | 0.210 |
Why?
| | Sirtuin 3 | 1 | 2024 | 60 | 0.200 |
Why?
| | Sezary Syndrome | 1 | 2023 | 45 | 0.200 |
Why?
| | Mycosis Fungoides | 1 | 2023 | 63 | 0.190 |
Why?
| | Sildenafil Citrate | 1 | 2023 | 60 | 0.190 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 1 | 2023 | 45 | 0.190 |
Why?
| | Cells, Cultured | 5 | 2021 | 4148 | 0.180 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2020 | 70 | 0.180 |
Why?
| | Antineoplastic Agents | 2 | 2024 | 2214 | 0.180 |
Why?
| | Purines | 1 | 2023 | 187 | 0.180 |
Why?
| | Macrophages, Alveolar | 2 | 2024 | 373 | 0.170 |
Why?
| | Histone Deacetylases | 2 | 2021 | 207 | 0.170 |
Why?
| | Antagomirs | 2 | 2017 | 12 | 0.170 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 270 | 0.170 |
Why?
| | Vasodilator Agents | 1 | 2023 | 330 | 0.170 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2021 | 92 | 0.160 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 362 | 0.160 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 162 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 93 | 0.160 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2020 | 449 | 0.160 |
Why?
| | Transcriptome | 2 | 2024 | 1038 | 0.160 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2023 | 248 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2021 | 181 | 0.150 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2020 | 90 | 0.150 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4560 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 171 | 0.140 |
Why?
| | RNA Interference | 2 | 2017 | 475 | 0.140 |
Why?
| | Mice, SCID | 3 | 2025 | 369 | 0.140 |
Why?
| | Humans | 18 | 2025 | 145475 | 0.130 |
Why?
| | Naphthoquinones | 1 | 2017 | 20 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2024 | 5983 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 561 | 0.130 |
Why?
| | Rats | 6 | 2024 | 5584 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1767 | 0.130 |
Why?
| | Chromatin | 1 | 2021 | 553 | 0.120 |
Why?
| | Complement Activation | 1 | 2020 | 399 | 0.120 |
Why?
| | Transcription, Genetic | 2 | 2021 | 1454 | 0.120 |
Why?
| | Energy Metabolism | 3 | 2017 | 935 | 0.120 |
Why?
| | Transcriptional Activation | 1 | 2018 | 372 | 0.120 |
Why?
| | Alcohol Oxidoreductases | 1 | 2016 | 61 | 0.120 |
Why?
| | Protein Isoforms | 1 | 2017 | 397 | 0.120 |
Why?
| | Skin Neoplasms | 1 | 2023 | 849 | 0.110 |
Why?
| | Mitochondria | 3 | 2017 | 992 | 0.110 |
Why?
| | Histones | 1 | 2021 | 666 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2020 | 892 | 0.110 |
Why?
| | Interleukin-1beta | 1 | 2017 | 389 | 0.110 |
Why?
| | Alternative Splicing | 1 | 2017 | 247 | 0.110 |
Why?
| | DNA Methylation | 1 | 2020 | 674 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2024 | 1789 | 0.100 |
Why?
| | RNA, Messenger | 1 | 2020 | 2803 | 0.090 |
Why?
| | Phenotype | 5 | 2020 | 3155 | 0.090 |
Why?
| | Mice, Inbred NOD | 2 | 2025 | 613 | 0.080 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 149 | 0.080 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 956 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2025 | 3542 | 0.080 |
Why?
| | Endothelial Cells | 3 | 2023 | 874 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2025 | 934 | 0.080 |
Why?
| | Biomarkers | 1 | 2021 | 4295 | 0.070 |
Why?
| | Heart Failure | 1 | 2023 | 2326 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1480 | 0.070 |
Why?
| | Cell Movement | 1 | 2013 | 959 | 0.070 |
Why?
| | Oxidation-Reduction | 3 | 2017 | 1067 | 0.070 |
Why?
| | Lung | 4 | 2024 | 4106 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2524 | 0.060 |
Why?
| | Superoxides | 2 | 2017 | 198 | 0.060 |
Why?
| | Antibodies, Monoclonal | 2 | 2024 | 1505 | 0.060 |
Why?
| | Allyl Compounds | 1 | 2024 | 25 | 0.050 |
Why?
| | Sirtuins | 1 | 2024 | 50 | 0.050 |
Why?
| | Receptors, CCR4 | 1 | 2024 | 24 | 0.050 |
Why?
| | Phenols | 1 | 2024 | 106 | 0.050 |
Why?
| | Swine, Miniature | 1 | 2024 | 89 | 0.050 |
Why?
| | Epigenesis, Genetic | 2 | 2018 | 679 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2020 | 3124 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2024 | 283 | 0.050 |
Why?
| | Physical Conditioning, Animal | 1 | 2024 | 242 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 121 | 0.040 |
Why?
| | Swine | 1 | 2024 | 825 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 574 | 0.040 |
Why?
| | Erlotinib Hydrochloride | 1 | 2021 | 72 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 112 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 500 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 278 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 297 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 247 | 0.040 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2020 | 12 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 33 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 442 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2022 | 635 | 0.040 |
Why?
| | Immunoglobulins | 1 | 2020 | 162 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 106 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 2020 | 121 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 161 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 187 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 734 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 666 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2023 | 756 | 0.030 |
Why?
| | Lim Kinases | 1 | 2017 | 5 | 0.030 |
Why?
| | Smad5 Protein | 1 | 2017 | 7 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Smad1 Protein | 1 | 2017 | 17 | 0.030 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 172 | 0.030 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 51 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2017 | 55 | 0.030 |
Why?
| | Metabolome | 1 | 2021 | 388 | 0.030 |
Why?
| | Symporters | 1 | 2017 | 48 | 0.030 |
Why?
| | Up-Regulation | 1 | 2020 | 847 | 0.030 |
Why?
| | Isoenzymes | 1 | 2017 | 294 | 0.030 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2016 | 9 | 0.030 |
Why?
| | Male | 5 | 2024 | 72843 | 0.030 |
Why?
| | Citric Acid Cycle | 1 | 2016 | 58 | 0.030 |
Why?
| | Carbon | 1 | 2017 | 176 | 0.030 |
Why?
| | Pyruvic Acid | 1 | 2016 | 51 | 0.030 |
Why?
| | Adventitia | 1 | 2016 | 42 | 0.030 |
Why?
| | Cell Respiration | 1 | 2016 | 105 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2016 | 42 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1188 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 531 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2016 | 67 | 0.030 |
Why?
| | Inflammation | 2 | 2020 | 2878 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 209 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 637 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1476 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 981 | 0.030 |
Why?
| | Down-Regulation | 1 | 2016 | 618 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 64 | 0.020 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 63 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 105 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 112 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 149 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 207 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2013 | 450 | 0.020 |
Why?
| | Glucose | 1 | 2017 | 1048 | 0.020 |
Why?
| | Female | 4 | 2025 | 78845 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1356 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4316 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1808 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2238 | 0.020 |
Why?
| | United States | 1 | 2023 | 16098 | 0.010 |
Why?
| | Adult | 1 | 2013 | 40777 | 0.000 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|